CRISPR biosensors are transforming healthcare by detecting biomarkers at attomolar sensitivity, enabling real-time health monitoring through wearable patches and implantable sensors. They continuously ...

It took five years to sequence the first human genome. Today, it takes less than 24 hours. Rapid genome sequencing is one of the many advances indebted to CRISPR-Cas9, the powerful gene editing ...

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...

Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today introduced its ...

Researchers at UC Berkeley and UC Riverside have merged computational and molecular biology to demonstrate the potential that gene modification may have in suppressing mosquito-borne diseases.

This GENcast is part 1 of a 3-part series on Cas-CLOVER, “the proven alternative to CRISPR-Cas9,” sponsored by Demeetra AgBio—exclusive Cas-CLOVER licensing partner for bioprocessing, synthetic ...

This article is based on a poster originally authored by Daniel Weekes, Blaise Louis, Sunil Modi, Erica Bello, Serena Belluschi, Tom Mitchell, Holly Herbert, Tarun Vemulkar, and Jeroen Verheyen, which ...